Neuropathology and Amyloid-β Spectrum in a Bapineuzumab Immunotherapy Recipient

The field of Alzheimer’s disease (AD) research eagerly awaits the results of a large number of Phase III clinical trials that are underway to investigate the effectiveness of anti-amyloid-β (Aβ) immunotherapy for AD. In this case report, we review the pertinent clinical history, examine the neuropat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Roher, Alex E., Maarouf, Chera L., Daugs, Ian D., Kokjohn, Tyler A., Hunter, Jesse M., Sabbagh, Marwan N., Beach, Thomas G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172868/
https://ncbi.nlm.nih.gov/pubmed/21263194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-2011-101809
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak